Effect of introducing biologics to patients with rheumatoid arthritis on the risk of venous thromboembolism: a nationwide cohort study
Abstract In the United States, 100,000–300,000 patients die from venous thromboembolism (VTE) each year, with more than 500,000 people related hospitalizations. While in Europe, 500,000 people die from VTE each year. Patients with rheumatoid arthritis are at increased risk of VTE. The use of biologi...
Saved in:
Main Authors: | Chao-Ping Chen, Pei-Tseng Kung, Wen-Yu Chou, Wen-Chen Tsai |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b2ae2c13e19b4187aadd387eb9e1870a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study.
by: Ole Ahlehoff, et al.
Published: (2011) -
Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study
by: Chan Mi Heo, et al.
Published: (2021) -
Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort.
by: Rie Adser Virkus, et al.
Published: (2014) -
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
by: Caroline Sindet-Pedersen, et al.
Published: (2017) -
A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
by: Ying Chen MB, et al.
Published: (2021)